AJMB-Avicenna Journal of Medical Biotechnology. 2018; 10 (3): 147-151
in English
| IMEMR
| ID: emr-202056
ABSTRACT
Background:
Biosynthetic teriparatide [1-34] [TPD] is a N-terminally truncated version of human parathyroid hormone [hPTH]. The recombinant form of this polypeptide has been expressed in Escherichia coli [E. coli] and approved as the first anabolic treatment of osteoporosis in the EU and the USA. Feasibility of expression and secretion of a tag- fused form of TPD into Bacillus subtilis [B. subtilis] was examined due to several advantages of B. subtilis over E. coli in production of recombinant proteins with pharmacological activities
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Language:
English
Journal:
Avicenna J. Med. Biotechnol.
Year:
2018
Similar
MEDLINE
...
LILACS
LIS